Tag: Pharmalittle
Pharmalittle: Updates on Charles River Monkey Shipments and VC Partners in China
Good day to you! The sun is shining, the birds are singing, and the Pharmalot campus is buzzing with activity. We're starting our day...
FDA Oversight of Drug Shortages and AstraZeneca Threats: Pharmalittle News Update
As the week comes to a close, many are looking forward to weekend plans. Whether it's enjoying the outdoors, planning a holiday break, or...
Target: Novo targeting compounded obesity drugs and Amgen ‘at risk’ launchNew Title: Novo Targets...
Hello, everyone! It's great to be here with you today. We hope you're all doing well and ready to dive into some interesting news....
New Title: CVS Appoints New Chief, Obesity Medications Lower Overdoses + More News
As the week comes to a close, many of us are looking forward to the weekend and making plans to relax and unwind. Here...
Alleged Pfizer Threats and Industry Payments: Pharmalittle News Update
As the week comes to a close, many of us are looking forward to the weekend. Whether it's spending time with family, enjoying the...
Pfizer’s Activist Investor, Medicare Costs for Obesity Drugs, and More: Pharmalittle Update
Good day to all our readers, we hope you are having a productive week so far. As we look forward to the weekend, let's...
Italian Acquisition and Medicare Advantage Market Growth in the Latest Pharmalittle Update
Good morning! This is Adam Feuerstein reporting from the Pharmalittle campus in Cambridge, Mass., filling in for our regular host Ed. Like Mr. Pharmalot,...
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
